Newron Pharmaceuticals SpA (NWRN) — Long-term Investment Intensity
Newron Pharmaceuticals SpA (NWRN) has a Long-term Investment Intensity of 1.6% as of December 2014. Long-term investments of CHF584.00K represent 1.6% of total assets of CHF37.07 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check NWRN cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Newron Pharmaceuticals SpA Long-term Investment Intensity (2013–2014)
This chart shows how Newron Pharmaceuticals SpA's Long-term Investment Intensity has evolved across 2 annual periods from 2013 to 2014. As of December 2014, the intensity stands at 1.6%, reflecting long-term investments of CHF584.00K against total assets of CHF37.07 Million CHF. For the complete balance sheet picture, see NWRN total assets.
Annual Long-term Investment Intensity for Newron Pharmaceuticals SpA (2013–2014)
The table below presents the year-by-year Long-term Investment Intensity for Newron Pharmaceuticals SpA from 2013 to 2014, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Newron Pharmaceuticals SpA balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2014 | 1.6% | CHF584.00K | CHF37.07 Million | ▼ -1.6 pp |
| 2013 | 3.2% | CHF1.00 Million | CHF31.62 Million | — |